Literature DB >> 15691339

Minocycline-associated intra-oral soft-tissue pigmentation: clinicopathologic correlations and review.

Vincent N LaPorta1, Nikolaos G Nikitakis, Arnold J Sindler, Mark A Reynolds.   

Abstract

BACKGROUND: Intra-oral minocycline staining of alveolar bone and teeth is well-described in the literature. Minocycline-induced discoloration of oral soft tissues is less common and has been often attributed to staining of the underlying bone. AIM: This report documents the clinical and histopathologic features of a case of actual oral soft tissue minocycline-induced pigmentation. The patient, a 45-year-old Caucasian female, presented with pigmentation of the gingiva, lips, and nail beds of recent onset. The past medical history revealed initiation of minocycline therapy 6 months earlier for dermatological concerns. Histopathologic examination of biopsy specimens from the gingiva and lip showed evidence of increased melanin/melanocytes in the epithelium and melanin/melanophages in the connective tissue. A working diagnosis of drug-associated pigmentation was determined and the patient discontinued immediately minocycline therapy. Nine months after cessation of minocycline the patient exhibited a marked reduction in pigmentation.
CONCLUSION: Systemic minocycline treatment has the potential to induce significant and esthetically objectionable discoloration of the gingiva and oral mucosa. A brief review of the literature is presented to help understand this uncommon finding that should be included in the differential diagnosis of spontaneous discoloration of intra-oral soft tissues. (c) Blackwell Munksgaard 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691339     DOI: 10.1111/j.1600-051X.2005.00646.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  6 in total

1.  Minocycline toxicity: case files of the University of Massachusetts medical toxicology fellowship.

Authors:  Matthew D Zuckerman; Katherine L Boyle; Christopher D Rosenbaum
Journal:  J Med Toxicol       Date:  2012-09

2.  Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures.

Authors:  Agustini Utari; Weerasak Chonchaiya; Susan M Rivera; Andrea Schneider; Randi J Hagerman; Sultana M H Faradz; Iryna M Ethell; Danh V Nguyen
Journal:  Am J Intellect Dev Disabil       Date:  2010-09

Review 3.  Medication-Induced Oral Hyperpigmentation: A Systematic Review.

Authors:  Nada O Binmadi; Maram Bawazir; Nada Alhindi; Hani Mawardi; Ghada Mansour; Sana Alhamed; Sarah Alfarabi; Sara Akeel; Soulafa Almazrooa
Journal:  Patient Prefer Adherence       Date:  2020-10-15       Impact factor: 2.711

4.  Staining of palatal torus secondary to long term minocycline therapy.

Authors:  Aravind Buddula
Journal:  J Indian Soc Periodontol       Date:  2009-01

Review 5.  Sensory Processing Phenotypes in Fragile X Syndrome.

Authors:  Maham Rais; Devin K Binder; Khaleel A Razak; Iryna M Ethell
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

6.  Minocycline-induced periarticular black bones in inflamed joints which underwent arthroplastic reconstruction.

Authors:  Suran Yang; Yuya Takakubo; Shinji Kobayashi; Tamon Asano; Akiko Sasaki; Kan Sasaki; Hiroharu Ohki; Yasunobu Tamaki; Michiaki Takagi
Journal:  Clin Orthop Surg       Date:  2012-08-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.